PhosphoLean NOPE + EGCG is a patented appetite suppressant compound that is clinically proven to help people stay on their diets.
PhosphoLean NOPE + EGCG is a patented appetite suppressant compound that is clinically proven to help people stay on their diets. PhosphoLean signals the brain to switch off the sensations of hunger and helps individuals manage their stressful diets and lower diet depression. PhosphoLean can be a keynote ingredient for a company’s next weight-management product.
Chemi Nutra
Booth 138
Judge in CRN’s complaint against NY denies the State’s motion to dismiss
Published: May 14th 2024 | Updated: May 15th 2024New York State's motion to dismiss CRN's lawsuit against the law banning the sale of weight management and muscle-building supplements to minors has been partially denied, allowing CRN to proceed with its First Amendment Claim.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.